Generate a tailored SOP for Dr. Andrei Thomas Tikhonenko. Improve your application with a focused, well-structured draft.
Andrei Thomas-Tikhonenko is a Professor in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine, University of Pennsylvania. He has a solid academic background with a BSc in Biochemistry/Virology from Moscow State University and a PhD in Oncology/Virology from the Russian Academy of Medical Sciences. His research focuses on the pathobiology of solid hematopoietic malignancies, particularly lymphomas and leukemias in both pediatric and adult cancers driven by MYC overexpression. His lab has notably explored non-coding RNAs' role in cancer pathogenesis and therapeutic resistance, including the significant discovery of MYC-regulated microRNAs that influence tumor growth and angiogenesis. He has participated in various collaborative projects and has contributed to the understanding of CD19-targeted immunotherapy, shaping new avenues for cancer treatments. His work has been recognized through multiple publications and collaborations, including the Pediatric Immunotherapy Discovery Development Network funded by the Beau Biden Cancer Moonshot Initiative. Thomas-Tikhonenko continues to investigate regulatory mechanisms of splicing in cancer, seeking to develop novel immunotherapeutic strategies.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.